Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.
Latest website image capture
Clouds background image

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new revision tag, v3.5.3, has been added to the page, replacing the previous v3.5.2. This reflects a small front-end/system update to the page rendering and metadata surrounding the study details, with no changes to the study content.
    Difference
    0.1%
    Check dated 2026-04-30T17:26:13.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added and v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:29:51.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now shown in the page footer, replacing the previous label. The prior Revision: v3.4.3 label has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:42:53.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:27.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1, and the funding-status notice has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T01:57:52.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, indicating information may not be up to date and transactions may not be processed until appropriations are enacted, with guidance to check status on cc.nih.gov and opm.gov. Updated the page revision tag to v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-03T23:25:35.000Z thumbnail image

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.